EPGNF OTC
Epigenomics AG
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +72.3%
5Y: -17.0%
$1.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
+52.5% ▲
Capital Expenditures
$3K
+99.8% ▲
5Y CAGR: -51.0%
Free Cash Flow
-$6M
+57.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$45K
+0.0% ▲
Net Change in Cash
-$6M
+55.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$17M | -$12M | -$2M | -$12M | -$4M |
| Depreciation & Amort. | $513K | $535K | $419K | $749K | $563K |
| Stock-Based Comp. | $873K | $631K | $98K | -$35K | $0 |
| Change in Working Capital | -$211K | $914K | -$988K | -$705K | -$345K |
| Other Non-Cash Items | -$107K | $35K | $57K | $50K | -$1M |
| Operating Cash Flow | -$14M | -$10M | -$4M | -$12M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$122K | -$21K | -$35K | -$1M | -$3K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $984K | $0 | $0 |
| Other Investing | $169K | $24K | $12K | -$335K | $71K |
| Investing Cash Flow | $47K | $3K | $961K | -$2M | $68K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $20M | -$18K | $0 |
| Stock Repurchased | -$983K | -$23K | -$79K | $0 | -$45K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$229K | -$993K | -$272K | -$341K | -$57K |
| Financing Cash Flow | $7M | $3M | $22M | -$359K | -$57K |
| Net Change in Cash | -$6M | -$7M | $19M | -$13M | -$6M |
| Cash End of Period | $10M | $4M | $23M | $10M | $2M |
| Free Cash Flow | -$14M | -$10M | -$4M | -$13M | -$6M |